Theriva Biologics, Inc. (TOVX) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TOVX Hot Sheet
Join SI Premium – FREE
Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Healthcare (ACHC) Tops Q3 EPS by 14c ; Offers Guidance
- AppLovin (APP) Tops Q3 EPS by 26c, Beats on Revenue; Offers Q4 Revenue Guidance
- Sinclair Broadcast Group (SBGI) Tops Q3 EPS by 31c; updates guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
